Brian T. Rekofke Attorney Witherspoon Kelley

Size: px
Start display at page:

Download "Brian T. Rekofke Attorney Witherspoon Kelley"

Transcription

1 Yuan-Po Tu, MD The Everett Clinic Urgent Care Provider Anticoagulation and Flu Services Medical Director, Brian T. Rekofke Attorney Witherspoon Kelley Largest independent medical group in the Pacific Northwest Located in 9 locations throughout Snohomish County 5th largest private employer in Snohomish County ~ 1,740 employees ~ 500 providers 295,000 patients 1,000,000 annual patient visits More than 40 medical specialties. FORTUNE Top 100 Best Workplace 1

2 To Ask a Question During the Presentation e mail us at TECEHR@gmail.com Disclosures and Conflict of Interests: Pharmaceutical Grants: Pharmaceutical Speaker Fees: Pharmaceutical Boards or Positions: None None None None The Everett Clinic uses EPIC Trade names of other Electronic Medical Record Systems will be used 2

3 Learning Objectives Understand rational and use of guidelines Legal and risk issues with guidelines How guidelines become standard of care Objectives: At End of the Session, Participants will Understand the rational for the development of guidelines Explain and illustrate best practices for the development of guidelines Understand and explain the legal and risk management issues associated with practice guidelines Understand the role of EMR in the use of guidelines and how EMR s can facilitate guideline implementation 3

4 Guidelines vs. Clinical Protocols Guidelines are intended to assist providers in advising patients on the use and best practice for diagnostic and therapeutic interventions. Protocols are intended to support non practitioner staff in applying care guideline clinic wide. Guideline Template 4

5 Guideline Template Preamble Summary Statement Intended Users Inclusions Exclusions Contraindications Supportive Background Management Actions EMR Documentation and EMR Tools/References/Bibliography/Related Links Document Control Indexing and search information Guidelines have existed for years. How have EMR s changed guidelines? 5

6 Major EMR Vendors Cerner HBOC McKesson acquired HBOC in 1999 Eclipsys Allscripts Eclipsys and Allscripts merged in 2010 Epic founded in 1979 as Human Services Computing Siemens IDX GE IDX acquired by GE in % 80% 60% 40% 20% 0% Circ EMR Adoption Small Practices Large Practices Hospital Outpatient Practices Hospital Inpatient And ICU s Complete Partial Paper Only 10% of Large Practices have Completely Integrated EMR s 6

7 More than 50% of the U.S. population will have their medical information stored in an Epic digital record Judy Faulkner Epic Deep Space User Group Meeting September 2013 The Affordable Care Act and Healthcare Economics Driving the change to Electronic Medical Records Meaningful Use 72% of all office based Health Care Providers use some form of Electronic Health Records (EHRs) adoption is anticipated to reach 80% by 2016 National Center for Health Statistics;

8 Cost of EMR Systems $700 M by U. of Pittsburg 2013 EMR s often represent one of the larger investments Health Exchanges ACO Radiology Growth Risk HCC Risk Adjusted Meaningful Use Medicare Operating Income Patient Satisfaction 8

9 EMR expose many system issues Greatest variability Rate limiting step Level Load the work and Standardize each step Standardize each step Lighten the provider s documentation burden Delegate all you can to support staff 9

10 Simplified Workflow BEGINNING MIDDLE END Registration Rooming Provider Assessment End Of Visit Reception Standards Standard Rooming Standard Visit Template Medical Decision Making Standard Protocols Simplified The Visit 1) Beginning Registration and Rooming 2) Middle Medical Decision Making Assessment and Diagnosis 3) End Orders Coding, Patient Instructions and Discharge Subject to Guidelines 10

11 Associated Symptoms: intended to uncover more serious/acute conditions 11

12 Guidelines are most helpful once a diagnosis is reached The more definitive the diagnosis, the more explicit the guidelines. Many medical diagnosis are not definitive but symptom complexes. (i.e. Chest Pain) Guidelines work best for definitive diagnosis. Strep Throat Protocols Well defined. National Guidelines. High Volume event Simple easy to obtain a diagnosis Low cost Rapid Test fast 20 minutes» 80 90% sensitive $35 Overnight Strep Culture No sensitivity testing» Gold Standard $35 Strep is the only common cause of a sore throat that is treated with antibiotics Low Risk Diagnosis and Treatment Cost of diagnosis is low. Cost of Treatment is low 12

13 Strep Throat Test sore throat with Rapid Strep Test No antibiotics if strep test is negative Children have back up cultures Treat with 10 days of antibiotics Penicillin First Choice Cephalexin if PCN Allergic 13

14 How do Guidelines work when you have something more complicated? Easy and Simple High Volume Low Risk Moderate Complexity High Volume Low to Moderate Risk Strep Treatment Urinary Tract Infection Treatment High Complexity Moderate Volume High Risk Chest Pain or DVT Treatment High Complexity Low Volume High Risk Post Exposure Prophylaxis 14

15 Uncomplicated Female UTI Treatment Moderate Complexity High Volume event More complexity to diagnosis Urinalysis fast 20 minutes» 80 90% sensitive $35 Culture and Sensitivity» Gold Standard $35 Multiple organisms diagnosis is more complex. Usually a Low Risk Diagnosis. Multiple Treatments Cost of Diagnosis is moderate, cost of Treatment is inexpensive Treatment of Deep Vein Thrombosis Diagnosis is usually definitive Venous Duplex Doppler is positive or negative Lots of different treatment options IV Heparin + Coumadin Low Molecular Weight Heparin + Coumadin Inpatient vs. Outpatient Newer TSOAC Rivaroxaban, Dabigatrin, etc. High Risk Medication 15

16 16

17 17

18 Why Guidelines? Mounting financial pressures Rapid spread of technology Need data to show improvement of care and performance Active management of Quality Improvement Continuous Quality Improvement 18

19 Guidelines Decrease Unexplained Variation Expert/evidence based guidelines Review critical checklists Enoxaparin Prescribing Review Acute DVT/PE n=51 Bridging Peri Op n=78 Thromboembolic Event 0/51 (0%) Thromboembolic Event 0/78 (0%) Minor Bleeding Event 12/51 (24%) Minor Bleeding Event 12/78 (15%) Correct Weight Dose 51/51 (100%) Correct Weight Dose 78/78 (100%) Correct Renal Dosing 51/51 (100%) Correct Renal Dosing 78/78 (100%) After switching from dalteparin to enoxaparin in April 2013, we conducted a review of all patient from April-July 2013 receiving a prescription of enoxaparin for treatment. 19

20 30% 25% 20% 15% 10% Anticoagulation Clinic Results 11.80% Usual medical care (no ACC clinic process) External ACC (benchmark) TEC ACC % 0% 3.90% 1.60% 1.95% 2.51% 2.50% 3.30% 0.60% 0.88% 0.85% TEC ACC 2011 Major bleeding Thromboembolism EMR allow organizations to crunch data EMR Analytics can allow for spotting trends Decision Support Diagnostic Guidelines Treatment Guidelines 20

21 Point of use Decision Support Helps uses pick the correct test. Are you looking to prove immunity? Or diagnose an infection? Laboratory Cost Analysis Cost per Test Name Cost # Tests # Positive % Positive Pos Test C. Difficile Toxins & GDH Antigen $ $ if positive, reflex to C. Diff PCR to PacLab $ Ova & Parasite Screen: $ $9, Entamoeba coli % Endolimax nana % Cryptosporidium species oocytes % Entamoeba hartmanii % Giardia lamblia % Giardia Ag $ $3, Stool Cultures $ $4, H. Pylori, Stool $ $6,

22 Point of Use Decision Support TEC background rate of positive O & P is approximately 1%. O and P is seldom positive unless the patient has had recent foreign travel or is severely immunosuppressed. If Giardia diarrhea is a concern, order Giardia Antigen (GIARD). If C. difficile diarrhea is a concern, order C. difficile (CTGD2). Scientific knowledge about best care is not applied systematically or expeditiously to clinical practice. It takes an average of 17 years for new knowledge generated by randomized controlled trails to be incorporated into practice. 22

23 Only 15 20% of Medical Practice has Grade A Evidence Based Medicine Dr. David Eddy 80% is the Art of Medicine Internal Data and Guidelines 23

24 Internal Laboratory Monitoring Detects Outbreak Intervention Acremonium An internal audit identified a cluster of positive fungal cultures The fungus was identified as Acremonium and was found in some of the atomizers used to provide anesthetic and preparation for patients undergoing nasal endoscopy procedures patients were potentially exposed. 34 had positive cultures. The remainder had negative culture or were not cultured. 24

25 Only patients who had endoscopy in a single department between March 1, 2012 and November 21, 2012 were potentially exposed. Patients who did not have endoscopy were not exposed. The standard cleaning processes in place were strengthened and no further positive cultures were obtained. The decision was subsequently made to transition to disposable devices. State and County Health officials were involved and support the steps taken. Acremonium Smart Set Using the Acremonium Smart Set 1) Will give you the correct CC 2) Will give you a progress note template 3) Will give you options to choose if you need to perform Endoscopy or cultures 4) Will allow you to easily enter a consult 5) Will give you the correct Dx so the patient will not be charged 6) Gives the correct Level of Service so the patient is not charged 7) Gives options for patient instructions 25

26 This link will bring in the past five fungal cultures This is where the idea for the new EHR starts getting a little complicated 26

27 Standard of Care A healthcare provider has a duty to exercise the degree of skill, care, and learning expected of a reasonably prudent healthcare provider in the State of Washington acting in the same or similar circumstances at the time of the care or treatment in question. The degree of care actually practiced by members of the medical profession is evidence of what is reasonably prudent. EMR Data & Standard of Care Utilizing internal data and trends to alter guidelines may impact standard of care from a state wide standard to facility specific standard 27

28 Risk Management Challenges Patient populations, resources, and infrastructure may impact individual hospital statistical outcomes. Exposes hospital to potential criticism regarding data production and analysis. Accuracy of data analysis and conclusions tested as with Peer Reviewed Literature. Questions to Consider How much scientific data and analysis is required to change the standard of care? Who decides? Who scrutinizes the information and course of treatment in the facility setting (peer review)? How is all this documented 28

29 Questions? The Everett Clinic Yuan-Po Tu, MD Brian T. Rekofke Attorney Witherspoon Kelley 29

U.S. MARKET OVERVIEW

U.S. MARKET OVERVIEW U.S. MARKET OVERVIEW Ambulatory Applications (Hospital-Owned Ambulatory Facilities) 2010 Year End Report This historical report of the U.S. hospital market is brought to you as an online resource from

More information

C-Difficile Infection Control and Prevention Strategies

C-Difficile Infection Control and Prevention Strategies C-Difficile Infection Control and Prevention Strategies Adrienne Mims, MD MPH VP, Chief Medical Officer Adrienne.Mims@AlliantQuality.org 1/18/2016 1 Disclosure This educational activity does not have commercial

More information

NOAC Reversal Agent Think Tank Follow-Up: Post Approval Safety & Effectiveness Pharmacoepidemiologic Approaches and Big Data

NOAC Reversal Agent Think Tank Follow-Up: Post Approval Safety & Effectiveness Pharmacoepidemiologic Approaches and Big Data NOAC Reversal Agent Think Tank Follow-Up: Post Approval Safety & Effectiveness Pharmacoepidemiologic Approaches and Big Data Nancy Dreyer, PhD Chief of Scientific Affairs Copyright 2014 Quintiles FDA Feb

More information

Low Molecular Weight Heparin. All Wales Medicines Strategy Group (AWMSG) Recommendations and advice

Low Molecular Weight Heparin. All Wales Medicines Strategy Group (AWMSG) Recommendations and advice Low Molecular Weight Heparin All Wales Medicines Strategy Group (AWMSG) Recommendations and advice Starting Point Low Molecular Weight Heparin (LMWH): Inhibits factor Xa and factor IIa (thrombin) Small

More information

ACUTE DVT MANAGEMENT Richard J. DeMasi, MD April 26, 2014

ACUTE DVT MANAGEMENT Richard J. DeMasi, MD April 26, 2014 ACUTE DVT MANAGEMENT Richard J. DeMasi, MD April 26, 2014 Thromboembolism epidemiology 5 million DVT s 900,000 PE s 290,000 fatalities Heit J. Blood. 2005;106:910. 10 VTE events Since this talk began DVT

More information

October 12, 2010. Dear Health Care Provider:

October 12, 2010. Dear Health Care Provider: DEPARTMENT OF SOCIAL SERVICES DIVISION OF MEDICAL SERVICES 700 GOVERNORS DRIVE PIERRE, SD 57501-2291 PHONE: 605-773-3495 FAX: 605-773-5246 WEB: dss.sd.gov October 12, 2010 Dear Health Care Provider: We

More information

New Oral Anticoagulants. How safe are they outside the trials?

New Oral Anticoagulants. How safe are they outside the trials? New Oral Anticoagulants How safe are they outside the trials? Objectives The need for anticoagulant therapy Indications for anticoagulation Traditional anticoagulant therapies Properties of new oral anticoagulants

More information

americanehr.com A Report by AmericanEHR Partners October 2011

americanehr.com A Report by AmericanEHR Partners October 2011 Market Share and Top 10 Rated Ambulatory EHR Products by Practice Size A Report by AmericanEHR Partners October 2011 americanehr.com Copyright AmericanEHR Partners 2011 Market Share and Top 10 Rated Ambulatory

More information

TRUSTED PATIENT EDUCATION FOR BETTER OUTCOMES. MICROMEDEX Patient Connect. Patient Education & Engagement

TRUSTED PATIENT EDUCATION FOR BETTER OUTCOMES. MICROMEDEX Patient Connect. Patient Education & Engagement TRUSTED PATIENT EDUCATION FOR BETTER OUTCOMES MICROMEDEX Patient Connect Patient Education & Engagement Trusted Patient Education for Better Outcomes All your training, experience, tools, and technology

More information

Reducing Adverse Drug Events With Anti Coagulation Clinics. McFarland Clinic. McFarland Protime Clinic 09/05/12

Reducing Adverse Drug Events With Anti Coagulation Clinics. McFarland Clinic. McFarland Protime Clinic 09/05/12 Reducing Adverse Drug Events With Anti Coagulation Clinics Dr. Donald Skinner, MD McFarland Clinic 182 Physicians (149 Shareholders) 40 Mid Level Providers 13 Administrators/Executive Directors 1,200 Support

More information

NIMC VTE Prophylaxis Section Audit and Reporting Tool User Guide

NIMC VTE Prophylaxis Section Audit and Reporting Tool User Guide NIMC VTE Prophylaxis Section Audit and Reporting Tool User Guide November 2013 Commonwealth of Australia 2013 This work is copyright. It may be reproduced in whole or in part for study or training purposes

More information

Status of Electronic Health Records in Missouri Hospitals HIDI SPECIAL REPORT JULY 2012

Status of Electronic Health Records in Missouri Hospitals HIDI SPECIAL REPORT JULY 2012 Status of Electronic Health Records in Missouri Hospitals HIDI SPECIAL REPORT JULY 2012 HIDI SPECIAL REPORT INTRODUCTION The steady progress that Missouri hospitals continue to demonstrate in their adoption

More information

National Guidance and New Protocols

National Guidance and New Protocols National Guidance and New Protocols Dr Jane Strong Consultant Haematologist DVT clinical lead Acute VTE chair DAWN AC Twentieth User Group Meeting 8 th October 2012 Autumn dawn Restless geese take flight

More information

REAL-TIME INTELLIGENCE FOR FASTER PATIENT INTERVENTIONS. MICROMEDEX 360 Care Insights. Real-Time Patient Intervention

REAL-TIME INTELLIGENCE FOR FASTER PATIENT INTERVENTIONS. MICROMEDEX 360 Care Insights. Real-Time Patient Intervention REAL-TIME INTELLIGENCE FOR FASTER PATIENT INTERVENTIONS MICROMEDEX 360 Care Insights Real-Time Patient Intervention Real-Time Intelligence for Fast Patient Interventions At your patient s side, developments

More information

PROTOCOL TITLE: Ambulatory Initiation and Management of Warfarin for Adults

PROTOCOL TITLE: Ambulatory Initiation and Management of Warfarin for Adults PROTOCOL NUMBER: 7 PROTOCOL TITLE: Ambulatory Initiation and Management of Warfarin for Adults THIS PROTOCOL APPLIES TO: UW Health Clinics: all adult outpatients with an active order for warfarin TARGET

More information

Dawning of a New Epoch in Harm Measurement

Dawning of a New Epoch in Harm Measurement Dawning of a New Epoch in Harm Measurement From Paleolithic Hunter Gathers to Holocene Farmers Jack Jordan Henry Ford Health System (This presenter has nothing to disclose) Objectives Implement strategies

More information

HERTFORDSHIRE MEDICINES MANAGEMENT COMMITTEE (HMMC) RIVAROXABAN RECOMMENDED see specific recommendations for licensed indications below

HERTFORDSHIRE MEDICINES MANAGEMENT COMMITTEE (HMMC) RIVAROXABAN RECOMMENDED see specific recommendations for licensed indications below Name: generic (trade) Rivaroxaban (Xarelto ) HERTFORDSHIRE MEDICINES MANAGEMENT COMMITTEE (HMMC) RIVAROXABAN RECOMMENDED see specific recommendations for licensed indications below What it is Indications

More information

Rivaroxaban: Prescribing Guidance for the treatment of provoked venous thromboembolism (VTE)

Rivaroxaban: Prescribing Guidance for the treatment of provoked venous thromboembolism (VTE) Rivaroxaban: Prescribing Guidance for the treatment of provoked venous thromboembolism (VTE) Amber Drug Level 2 Leeds We have started your patient on rivaroxaban for the treatment of provoked VTE (deep

More information

National Guidance and New Protocols

National Guidance and New Protocols National Guidance and New Protocols Dr Jane Strong Consultant Haematologist DVT clinical lead Acute VTE chair DAWN AC Twentieth User Group Meeting 8 th October 2012 DVT patient pathway Assessment Diagnosis

More information

1. How are you using health IT enabled clinical quality measures for internal quality improvement efforts and patients care?

1. How are you using health IT enabled clinical quality measures for internal quality improvement efforts and patients care? 1. How are you using health IT enabled clinical quality measures for internal quality improvement efforts and patients care? Sharp Rees-Stealy medical group (SRSMG), a 400-physician multispecialty group

More information

Strategic Opportunities and Challenges in Telemedicine ALEXANDER NASON JOHNS HOPKINS MEDICINE INTERACTIVE PROGRAM DIRECTOR ANASON@JHMI.

Strategic Opportunities and Challenges in Telemedicine ALEXANDER NASON JOHNS HOPKINS MEDICINE INTERACTIVE PROGRAM DIRECTOR ANASON@JHMI. Strategic Opportunities and Challenges in Telemedicine ALEXANDER NASON JOHNS HOPKINS MEDICINE INTERACTIVE PROGRAM DIRECTOR ANASON@JHMI.EDU Agenda Landscape @ Johns Hopkins Medicine Telemedicine Primer

More information

How To Take Xarelto

How To Take Xarelto A patient's guide Your clinic's contact details are: Name: Contact number: Contents 2 Why have I been prescribed Xarelto? 2 What is Xarelto? 3 How do I take Xarelto? 3 What should I do if I miss a dose

More information

See page 331 of HEDIS 2013 Tech Specs Vol 2. HEDIS specs apply to plans. RARE applies to hospitals. Plan All-Cause Readmissions (PCR) *++

See page 331 of HEDIS 2013 Tech Specs Vol 2. HEDIS specs apply to plans. RARE applies to hospitals. Plan All-Cause Readmissions (PCR) *++ Hospitalizations Inpatient Utilization General Hospital/Acute Care (IPU) * This measure summarizes utilization of acute inpatient care and services in the following categories: Total inpatient. Medicine.

More information

A review of the public health response to two pertussis outbreaks in Maryland: Lessons Learned

A review of the public health response to two pertussis outbreaks in Maryland: Lessons Learned A review of the public health response to two pertussis outbreaks in Maryland: Lessons Learned Presenter: Kristen George MPH Candidate Johns Hopkins University Bloomberg School of Public Health Preceptor:

More information

Confirmed Deep Vein Thrombosis (DVT)

Confirmed Deep Vein Thrombosis (DVT) Confirmed Deep Vein Thrombosis (DVT) Information for patients What is deep vein thrombosis? Blood clotting provides us with essential protection against severe loss of blood from an injury to a vein or

More information

Empowering Value-Based Healthcare

Empowering Value-Based Healthcare Empowering Value-Based Healthcare Episode Connect, Remedy s proprietary suite of software applications, is a powerful platform for managing value based payment programs. Delivered via the web or mobile

More information

SURVEY QUESTIONNAIRE 2013 AHA ANNUAL SURVEY INFORMATION TECHNOLOGY SUPPLEMENT

SURVEY QUESTIONNAIRE 2013 AHA ANNUAL SURVEY INFORMATION TECHNOLOGY SUPPLEMENT 2013 AHA ANNUAL SURVEY INFORMATION TECHNOLOGY SUPPLEMENT SURVEY QUESTIONNAIRE This survey instrument can be used to facilitate sales, planning and marketing activities. For example, consider current and

More information

Community Oncology 2.0 Information Technology A Practical Guide: Navigating from Today to Tomorrow

Community Oncology 2.0 Information Technology A Practical Guide: Navigating from Today to Tomorrow Community Oncology 2.0 Information Technology A Practical Guide: Navigating from Today to Tomorrow Lucio Gordan, MD Florida Cancer Specialists Medical Informatics and Integrated Clinical Services COA National

More information

Investor News. Not intended for U.S. and UK media

Investor News. Not intended for U.S. and UK media Investor News Not intended for U.S. and UK media Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Bayer s Xarelto (Rivaroxaban) Approved for the Treatment of Pulmonary Embolism

More information

Clintegrity 360 QualityAnalytics

Clintegrity 360 QualityAnalytics WHITE PAPER Clintegrity 360 QualityAnalytics Bridging Clinical Documentation and Quality of Care HEALTHCARE EXECUTIVE SUMMARY The US Healthcare system is undergoing a gradual, but steady transformation.

More information

WHITE PAPER. QualityAnalytics. Bridging Clinical Documentation and Quality of Care

WHITE PAPER. QualityAnalytics. Bridging Clinical Documentation and Quality of Care WHITE PAPER QualityAnalytics Bridging Clinical Documentation and Quality of Care 2 EXECUTIVE SUMMARY The US Healthcare system is undergoing a gradual, but steady transformation. At the center of this transformation

More information

Service Specification Template Department of Health, updated June 2015

Service Specification Template Department of Health, updated June 2015 Service Specification Template Department of Health, updated June 2015 Service Specification No. : 2 Service: Commissioner Lead: Provider Lead: Period: Anti-coagulation monitoring Date of Review: 31 st

More information

Case Study: Using Predictive Analytics to Reduce Sepsis Mortality

Case Study: Using Predictive Analytics to Reduce Sepsis Mortality Case Study: Using Predictive Analytics to Reduce Sepsis Mortality 1 Learning Objectives 1. Understand how an automated, real time IT intervention can help care teams recognize and intervene on critical,

More information

Empowering Value-Based Healthcare

Empowering Value-Based Healthcare Empowering Value-Based Healthcare Episode Connect, Remedy s proprietary suite of software applications, is a powerful platform for managing value-based payment programs. Delivered via the web or mobile

More information

AHAdatainfo@healthforum.com 866-375-3633. 2012 AHA Annual Survey Information Technology Supplement. Healthcare IT Database Download and Data Licensing

AHAdatainfo@healthforum.com 866-375-3633. 2012 AHA Annual Survey Information Technology Supplement. Healthcare IT Database Download and Data Licensing 2012 AHA Annual Survey Information Technology Supplement Survey Questionnaire This survey instrument can be used to facilitate sales, planning and marketing activities. For example, consider current and

More information

Traditional anticoagulants

Traditional anticoagulants TEGH Family Practice Clinic Day April 4, 03 Use of Anticoagulants in 03: What s New (and What Isn t) Bill Geerts, MD, FRCPC Director, Thromboembolism Program, Sunnybrook HSC Professor of Medicine, University

More information

Dr. Peters has declared no conflicts of interest related to the content of his presentation.

Dr. Peters has declared no conflicts of interest related to the content of his presentation. Dr. Peters has declared no conflicts of interest related to the content of his presentation. Steve G. Peters MD NAMDRC 2013 No financial conflicts No off-label usages If specific vendors are named, will

More information

Clinical Study Synopsis

Clinical Study Synopsis Clinical Study Synopsis This Clinical Study Synopsis is provided for patients and healthcare professionals to increase the transparency of Bayer's clinical research. This document is not intended to replace

More information

2. Background This indication of rivaroxaban had not previously been considered by the PBAC.

2. Background This indication of rivaroxaban had not previously been considered by the PBAC. PUBLIC SUMMARY DOCUMENT Product: Rivaroxaban, tablets, 15mg and 20mg, Xarelto Sponsor: Bayer Australia Ltd Date of PBAC Consideration: March 2013 1. Purpose of Application The application requested the

More information

Committee Approval Date: September 12, 2014 Next Review Date: September 2015

Committee Approval Date: September 12, 2014 Next Review Date: September 2015 Medication Policy Manual Policy No: dru361 Topic: Pradaxa, dabigatran Date of Origin: September 12, 2014 Committee Approval Date: September 12, 2014 Next Review Date: September 2015 Effective Date: November

More information

Using CDS (Clinical Decision Support) for Quality Initiatives at a Community Hospital

Using CDS (Clinical Decision Support) for Quality Initiatives at a Community Hospital Using CDS (Clinical Decision Support) for Quality Initiatives at a Community Hospital Jonathan Sykes MD, CMIO Jacalyn Liebowitz RN, MBA,NEA-BCFACHE VP Care Continuum Allegiance Health - Jackson, MI DISCLAIMER:

More information

Medical Informatics: Why Care? Kevin Chang, MD, MS Scott and White Healthcare 8/13/2013

Medical Informatics: Why Care? Kevin Chang, MD, MS Scott and White Healthcare 8/13/2013 Medical Informatics: Why Care? Kevin Chang, MD, MS Scott and White Healthcare 8/13/2013 About me Education and Training 1998 2004 UMKC School of Medicine, BA Chemistry, MD 2004 2008 UTMB Austin IM Resident

More information

National Quality Forum Safe Practices for Better Healthcare

National Quality Forum Safe Practices for Better Healthcare National Quality Forum Safe Practices for Better Healthcare UCLA Health System advocates the National Quality Forum (NQF) endorsed safe practices.this set of safe Practices encompasses 34 practices that

More information

2015 Data Validation Strategy

2015 Data Validation Strategy 2015 Data Validation Strategy This data validation strategy details how the American College of Emergency Physicians (ACEP), a medical specialty society representing more than 33,000 emergency physicians,

More information

Overview of the TJC/CMS VTE Core Measures

Overview of the TJC/CMS VTE Core Measures Overview of the TJC/CMS VTE Core Measures CMS Specification Manual 4.2 January 1, 2013 June 30, 2013 Victoria Agramonte, RN, MSN Project Manager, IPRO VTE Regional Learning Sessions NYS Partnership for

More information

Health Information Technology

Health Information Technology Health Information Technology chartbook volume II Maine Hospitals Survey 2010 UNIVERSITY OF SOUTHERN MAINE Health Information Technology Maine Hospitals Survey Volume II Authors Martha Elbaum Williamson,

More information

DVT/PE Management with Rivaroxaban (Xarelto)

DVT/PE Management with Rivaroxaban (Xarelto) DVT/PE Management with Rivaroxaban (Xarelto) Rivaroxaban is FDA approved for the acute treatment of DVT and PE and reduction in risk of recurrence of DVT and PE. FDA approved indications: Non valvular

More information

Enterprise Analytics Strategic Planning

Enterprise Analytics Strategic Planning Enterprise Analytics Strategic Planning June 5, 2013 1 "The first question a data driven organization needs to ask itself is not "what do we think?" but rather "what do we know? Big Data: The Management

More information

Anticoagulant therapy

Anticoagulant therapy Anticoagulation: The risks Anticoagulant therapy 1990 2002: 600 incidents reported 120 resulted in death of patient 92 deaths related to warfarin usage 28 reports related to heparin usage Incidents in

More information

A Plan For Better Health

A Plan For Better Health A Plan For Better Health Welcome to Crystal Run Health Plans PPO Plans Your health and that of your family is most important. Your health plan should be designed for all your needs giving you access to

More information

Integration for your Health Information System

Integration for your Health Information System Integration for your Health Information System Achieve comprehensive healthcare IT integration that leverages your existing IT investments and helps you meet the growing demands of Meaningful Use, HIE,

More information

Failure or significant adverse effects to all of the alternatives: Eliquis and Xarelto

Failure or significant adverse effects to all of the alternatives: Eliquis and Xarelto This policy has been developed through review of medical literature, consideration of medical necessity, generally accepted medical practice standards, and approved by the IEHP Pharmacy and Therapeutics

More information

HIMSS Electronic Health Record Definitional Model Version 1.0

HIMSS Electronic Health Record Definitional Model Version 1.0 HIMSS Electronic Health Record Definitional Model Version 1.0 Prepared by HIMSS Electronic Health Record Committee Thomas Handler, MD. Research Director, Gartner Rick Holtmeier, President, Berdy Systems

More information

Unity Point Health PROBLEM LISTS IN THE ELECTRONIC HEALTH RECORD

Unity Point Health PROBLEM LISTS IN THE ELECTRONIC HEALTH RECORD Unity Point Health PROBLEM LISTS IN THE ELECTRONIC HEALTH RECORD Introduction The problem list is a critical part of electronic documentation and serves as a communication tool between all care providers.

More information

Hospital Inpatient Quality Reporting (IQR) Program

Hospital Inpatient Quality Reporting (IQR) Program Clinical Process Measures Program Changes for Fiscal Year 2014 Beginning with January 1, 2012 discharges; hospitals will begin data collection and submission for 4 new measures. Hospitals will not be required

More information

Use of Antithrombotic Agents In The Presence Of Neuraxial Anesthesia

Use of Antithrombotic Agents In The Presence Of Neuraxial Anesthesia Use of Antithrombotic Agents In The Presence Of Neuraxial Anesthesia Insertion, removal or presence of a catheter in selected sites can place a patient who is antithrombotic agent at risk for a local bleeding

More information

Inpatient Anticoagulation Safety. To provide safe and effective anticoagulation therapy through a collaborative approach.

Inpatient Anticoagulation Safety. To provide safe and effective anticoagulation therapy through a collaborative approach. Inpatient Anticoagulation Safety Purpose: Policy: To provide safe and effective anticoagulation therapy through a collaborative approach. Upon the written order of a physician, Heparin, Low Molecular Weight

More information

Patient Group Direction Hospital: Bristol Royal Infirmary Department: UHBristol Thrombosis Service University Hospitals Bristol NHS Foundation Trust.

Patient Group Direction Hospital: Bristol Royal Infirmary Department: UHBristol Thrombosis Service University Hospitals Bristol NHS Foundation Trust. Patient Group Direction Hospital: Bristol Royal Infirmary Department: UHBristol Thrombosis Service University Hospitals Bristol NHS Foundation Trust. This Patient Group Direction (PGD) has been written

More information

Examination Content Blueprint

Examination Content Blueprint Examination Content Blueprint Overview The material on NCCPA s certification and recertification exams can be organized in two dimensions: (1) organ systems and the diseases, disorders and medical assessments

More information

How to Conduct a Thorough CAC Readiness Assessment

How to Conduct a Thorough CAC Readiness Assessment WHITE PAPER How to Conduct a Thorough CAC Readiness Assessment A White Paper from Nuance Healthcare HEALTHCARE COMPUTER-ASSISTED CODING Contents Introduction... 3 The Benefits of CAC... 4 The New Role

More information

Relevant Quality Measures for Critical Access Hospitals

Relevant Quality Measures for Critical Access Hospitals Policy Brief #5 January 0 Relevant Quality Measures for Critical Access Hospitals Michelle Casey MS, Ira Moscovice PhD, Jill Klingner RN, PhD, Shailendra Prasad MD, MPH University of Minnesota Rural Health

More information

Chapter 4 Health Care Management Unit 1: Care Management

Chapter 4 Health Care Management Unit 1: Care Management Chapter 4 Health Care Unit 1: Care In This Unit Topic See Page Unit 1: Care Care 2 6 Emergency 7 4.1 Care Healthcare Healthcare (HMS), Highmark Blue Shield s medical management division, is responsible

More information

Stroke/VTE Quality Measure Build for Meaningful Use Stage 1

Stroke/VTE Quality Measure Build for Meaningful Use Stage 1 Stroke/VTE Quality Measure Build for Meaningful Use Stage 1 Presented by Susan Haviland, BSN RN Senior Consult, Santa Rosa Consulting Meaningful Use Quality Measures Centers for Medicare and Medicaid Services

More information

Open Platform. Clinical Portal. Provider Mobile. Orion Health. Rhapsody Integration Engine. RAD LAB PAYER Rx

Open Platform. Clinical Portal. Provider Mobile. Orion Health. Rhapsody Integration Engine. RAD LAB PAYER Rx Open Platform Provider Mobile Clinical Portal Engage Portal Allegro PRIVACY EMR Connect Amadeus Big Data Engine Data Processing Pipeline PAYER CLINICAL CONSUMER CUSTOM Open APIs EMPI TERMINOLOGY SERVICES

More information

Title Use of rivaroxaban in suspected DVT in the Emergency Department Standard Operating Procedure. Author s job title. Pharmacist.

Title Use of rivaroxaban in suspected DVT in the Emergency Department Standard Operating Procedure. Author s job title. Pharmacist. Document Control Title Use of rivaroxaban in suspected DVT in the Emergency Department Author Pharmacist Directorate Clinical Support Services Version Date Issued Status 0.1 Oct Draft 2015 1.0 Dec Final

More information

A Guide to Patient Services. Cedars-Sinai Health Associates

A Guide to Patient Services. Cedars-Sinai Health Associates A Guide to Patient Services Cedars-Sinai Health Associates Welcome Welcome to Cedars-Sinai Health Associates. We appreciate the trust you have placed in us by joining our dedicated network of independent-practice

More information

Prostate Assessment Pathway Prostate Biopsy Alerts

Prostate Assessment Pathway Prostate Biopsy Alerts Prostate Assessment Pathway Prostate Biopsy Alerts Guidelines for the Management of Patient Preparation, Medications and Complications July 2015 Table of Contents Roles and Responsibilities. 1 SECTION

More information

Preventing Blood Clots in Adult Patients. Information For Patients

Preventing Blood Clots in Adult Patients. Information For Patients Preventing Blood Clots in Adult Patients Information For Patients 1 This leaflet will give you information on how to reduce the risk of developing blood clots during and after your stay in hospital. If

More information

Updates to the Alberta Drug Benefit List. Effective January 1, 2016

Updates to the Alberta Drug Benefit List. Effective January 1, 2016 Updates to the Alberta Drug Benefit List Effective January 1, 2016 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone Number: (780)

More information

To Bridge or Not to Bridge. Periop Anticoagulation Management. Don Weinshenker, MD Ambulatory Care Denver VAMC

To Bridge or Not to Bridge. Periop Anticoagulation Management. Don Weinshenker, MD Ambulatory Care Denver VAMC To Bridge or Not to Bridge Periop Anticoagulation Management Don Weinshenker, MD Ambulatory Care Denver VAMC Financial Disclosure Information Nothing to report Periop AC Management Chronically anti-coagulated

More information

September 12, 2011. Dear Dr. Corrigan:

September 12, 2011. Dear Dr. Corrigan: September 12, 2011 Janet M. Corrigan, PhD, MBA President and Chief Executive Officer National Quality Forum 601 13th Street, NW Suite 500 North Washington, D.C. 20005 Re: Measure Applications Partnership

More information

How To Treat An Elderly Patient

How To Treat An Elderly Patient 1. Introduction/ Getting to know our Seniors a. Identify common concepts and key terms used when discussing geriatrics b. Distinguish between different venues of senior residence c. Advocate the necessity

More information

Meaningful Use. Medicare and Medicaid EHR Incentive Programs

Meaningful Use. Medicare and Medicaid EHR Incentive Programs Meaningful Use Medicare and Medicaid Table of Contents What is Meaningful Use?... 1 Table 1: Patient Benefits... 2 What is an EP?... 4 How are Registration and Attestation Being Handled?... 5 What are

More information

Updates to the Alberta Human Services Drug Benefit Supplement

Updates to the Alberta Human Services Drug Benefit Supplement Updates to the Alberta Human Services Drug Benefit Supplement Effective January 1, 2016 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone

More information

For sample use only - data from 2006.

For sample use only - data from 2006. Essentials of the U.S. Hospital IT Market 1st Edition For sample use only - data from 2006. Electronic Medical Records 2426-7000 himss titles 3/9/06 9:34 AM Page 12 111 Approximately 75 percent of U.S.

More information

Value-Based Purchasing

Value-Based Purchasing Emerging Topics in Healthcare Reform Value-Based Purchasing Janssen Pharmaceuticals, Inc. Value-Based Purchasing The Patient Protection and Affordable Care Act (ACA) established the Hospital Value-Based

More information

Collaborative Practice Agreement for Nurse Practitioner Management of Patients in the Specialty of Pediatric Critical Care

Collaborative Practice Agreement for Nurse Practitioner Management of Patients in the Specialty of Pediatric Critical Care Collaborative Practice Agreement for Nurse Practitioner Management of Patients in the Specialty of Pediatric Critical Care Purpose Section I Introduction/Overview This document authorizes the nurse practitioner

More information

Environmental Health Science. Brian S. Schwartz, MD, MS

Environmental Health Science. Brian S. Schwartz, MD, MS Environmental Health Science Data Streams Health Data Brian S. Schwartz, MD, MS January 10, 2013 When is a data stream not a data stream? When it is health data. EHR data = PHI of health system Data stream

More information

Entity Overview and EMR Implementation Status. EMR Implementation: Compliance Challenges. Panel Members 11/29/2013. Moderator: Lynda Hilliard

Entity Overview and EMR Implementation Status. EMR Implementation: Compliance Challenges. Panel Members 11/29/2013. Moderator: Lynda Hilliard EMR Implementation: Compliance Challenges HCCA Upper West Coast Regional Conference December 6, 2013 San Francisco Panel Members Greta Fees Ginny Kim Kevin Longo Moderator: Lynda Hilliard Entity Overview

More information

9/28/15. Dabigatran. Rivaroxaban. Apixaban. Edoxaban. From the AC Forum Centers of Excellence website: Dabigatran, Rivaroxaban, & Apixaban

9/28/15. Dabigatran. Rivaroxaban. Apixaban. Edoxaban. From the AC Forum Centers of Excellence website: Dabigatran, Rivaroxaban, & Apixaban Identify the FDA approved direct oral anticoagulants (DOACs) Linda Kelly, PharmD, PhC, CACP Presbyterian Healthcare Services Distinguish the differences in the dosing of DOACs for various indications Describe

More information

EMR Implementation: Compliance Challenges

EMR Implementation: Compliance Challenges EMR Implementation: Compliance Challenges HCCA Upper West Coast Regional Conference December 6, 2013 San Francisco Panel Members Greta Fees Ginny Kim Kevin Longo Sutter Health John Muir Health Adventist

More information

Randomized, double-blind, parallel-group, multicenter, doubledummy

Randomized, double-blind, parallel-group, multicenter, doubledummy ABOUT RECORD STUDIES FAST FACTS RECORD is a global program of four trials in more than 12,500 patients, comparing Xarelto (rivaroxaban) and enoxaparin in the prevention of venous thromboembolism (VTE)

More information

Announcements. Upcoming Report Dates 3/12/2013. Best Practices to Improve Your Hospital Outpatient Quality Reporting.

Announcements. Upcoming Report Dates 3/12/2013. Best Practices to Improve Your Hospital Outpatient Quality Reporting. Best Practices to Improve Your Hospital Outpatient Quality Reporting March 20, 2013 Announcements This program has been approved for 1.0 continuing education unit (CEU) given by Continuing Education (CE)

More information

Licensed Healthcare Providers Guidelines for Telemedicine Using the MyDocNow Platform

Licensed Healthcare Providers Guidelines for Telemedicine Using the MyDocNow Platform Contents 1. Scope of These Guidelines... 2 2. What is Telemedicine?... 2 3. Introduction... 3 4. What Are the Benefits of Telemedicine?... 3 5. Frequently Asked Questions Physician Care and Treatment...

More information

convey the clinical quality measure's title, number, owner/developer and contact

convey the clinical quality measure's title, number, owner/developer and contact CMS-0033-P 153 convey the clinical quality measure's title, number, owner/developer and contact information, and a link to existing electronic specifications where applicable. TABLE 20: Proposed Clinical

More information

ORAL ANTICOAGULANTS - RIVAROXABAN (XARELTO) FOR DEEP VEIN THROMBOSIS (DVT)

ORAL ANTICOAGULANTS - RIVAROXABAN (XARELTO) FOR DEEP VEIN THROMBOSIS (DVT) ORAL ANTICOAGULANTS - RIVAROXABAN (XARELTO) FOR DEEP VEIN THROMBOSIS (DVT) Information Leaflet Your Health. Our Priority. Page 2 of 6 What Are Anticoagulants And What Do They Do? This information leaflet

More information

ORAL ANTICOAGULANTS RIVAROXABAN (XARELTO) FOR PULMONARY EMBOLISM (PE)

ORAL ANTICOAGULANTS RIVAROXABAN (XARELTO) FOR PULMONARY EMBOLISM (PE) ORAL ANTICOAGULANTS RIVAROXABAN (XARELTO) FOR PULMONARY EMBOLISM (PE) Information Leaflet Your Health. Our Priority. Page 2 of 6 What Are Anticoagulants And What Do They Do? This information leaflet has

More information

Measure Name: URI Treatment without Antibiotics for Children Measure Code: URI Lab Data: N

Measure Name: URI Treatment without Antibiotics for Children Measure Code: URI Lab Data: N Measure Name: URI Treatment without Antibiotics for Children Owner: NCQA (URI) Measure Code: URI Lab Data: N Rule Description: General Criteria Summary The percentage of children 3 months -18 years of

More information

Health IT: The Use of Diagnostic Decision Support Systems (DDSS) David C Classen MD MS University of Utah Pascal Metrics

Health IT: The Use of Diagnostic Decision Support Systems (DDSS) David C Classen MD MS University of Utah Pascal Metrics Health IT: The Use of Diagnostic Decision Support Systems (DDSS) David C Classen MD MS University of Utah Pascal Metrics Quick Medical Reference (QMR) : 1986 PATIENT-BASED DECISION SUPPORT SYSTEMS:

More information

Transitions of Care Management Coding (TCM Code) Tutorial. 1. Introduction Meaning of moderately and high complexity 2

Transitions of Care Management Coding (TCM Code) Tutorial. 1. Introduction Meaning of moderately and high complexity 2 Transitions of Care Management Coding (TCM Code) Tutorial Index 1. Introduction Meaning of moderately and high complexity 2 2. SETMA s Tools for using TCM Code 3 Alert that patient is eligible for TCM

More information

Venous Thromboembolism: Long Term Anticoagulation. Dan Johnson, Pharm.D.

Venous Thromboembolism: Long Term Anticoagulation. Dan Johnson, Pharm.D. Venous Thromboembolism: Long Term Anticoagulation Dan Johnson, Pharm.D. Disclosures No financial relationships with products discussed Off-label use of drug therapy always discussed Objectives Review clinical

More information

DATE: 06 May 2013 CONTEXT AND POLICY ISSUES

DATE: 06 May 2013 CONTEXT AND POLICY ISSUES TITLE: Low Molecular Weight Heparins versus New Oral Anticoagulants for Long-Term Thrombosis Prophylaxis and Long-Term Treatment of DVT and PE: A Review of the Clinical and Cost-Effectiveness DATE: 06

More information

What is Imaging Appropriateness and Utilization Management?

What is Imaging Appropriateness and Utilization Management? Economic Update AMCLC 2014 Christopher G. Ullrich MD FACR Chair, ACR Utilization Management Committee Imaging Appropriateness and Utilization Management Accountable Care Organizations Economic and Political

More information

Consultation: Two proposals for registered nurse prescribing

Consultation: Two proposals for registered nurse prescribing Consultation: Two proposals for registered nurse prescribing Submission Form Please read and refer to the consultation document Two proposals for registered nurse prescribing available on the Nursing Council

More information

CMS Data What s In It & How To Use It. Kimberly Kauffman Executive Director Summit Health Solutions

CMS Data What s In It & How To Use It. Kimberly Kauffman Executive Director Summit Health Solutions CMS Data What s In It & How To Use It Kimberly Kauffman Executive Director Summit Health Solutions 2 Summit Health Solutions ACO w/ July 1, 2012 start date Wholly owned by Summit Medical Group Two hospital

More information

Re: Medicare and Medicaid Programs; Electronic Health Record Incentive Program Modifications to Meaningful Use in 2015 through 2017; Proposed Rule

Re: Medicare and Medicaid Programs; Electronic Health Record Incentive Program Modifications to Meaningful Use in 2015 through 2017; Proposed Rule Submitted Electronically Andrew M. Slavitt Acting Administrator Centers for Medicare & Medicaid Services Department of Health and Human Services Attn: CMS-3311-P P.O. Box 8013 Baltimore, MD 21244-1850

More information

Table of Contents. Preface... 1. 1 CPSA Position... 2. 1.1 How EMRs and Alberta Netcare are Changing Practice... 2. 2 Evolving Standards of Care...

Table of Contents. Preface... 1. 1 CPSA Position... 2. 1.1 How EMRs and Alberta Netcare are Changing Practice... 2. 2 Evolving Standards of Care... March 2015 Table of Contents Preface... 1 1 CPSA Position... 2 1.1 How EMRs and Alberta Netcare are Changing Practice... 2 2 Evolving Standards of Care... 4 2.1 The Medical Record... 4 2.2 Shared Medical

More information

MarketsandMarkets. sales@marketsandmarkets.com www.marketsandmarkets.com

MarketsandMarkets. sales@marketsandmarkets.com www.marketsandmarkets.com U.S. ELECTRONIC MEDICAL RECORDS (EMR - PHYSICIAN OFFICE & HOSPITAL) MARKET - Emerging Trends (Smart Cards, Speech Enabled EMR), Market Share, Winning Strategies, Adoption & Forecasts till 2015 MarketsandMarkets

More information